BIPOC Patients Living With AML | Mortality Rate and Favorable Genetics Patient Empowerment Network 4:31 1 year ago 21 Далее Скачать
Dr. Erba on Tipifarnib for the Treatment of Older Patients With AML Targeted Oncology 2:21 10 years ago 200 Далее Скачать
Dr Erba on the Safety of Quizartinib By Treatment Phase and Age in FLT3-ITD–positive AML OncLive 2:13 5 months ago 86 Далее Скачать
What is the prognosis for acute myeloid leukemia (AML)? You and AML 1:17 5 years ago 17 718 Далее Скачать
Clinical value of event-free survival in AML VJHemOnc – Video Journal of Hematology & HemOnc 3:30 4 years ago 254 Далее Скачать
Limitations of targeted therapy for AML VJHemOnc – Video Journal of Hematology & HemOnc 4:31 6 years ago 230 Далее Скачать
The importance of MRD in AML prognosis and therapy VJHemOnc – Video Journal of Hematology & HemOnc 2:16 2 years ago 102 Далее Скачать
Safety by treatment phase and age when treating FLT3-ITD-mutated AML with quizartinib and chemo VJHemOnc – Video Journal of Hematology & HemOnc 5:24 10 months ago 71 Далее Скачать
Is there a cure for AML? #AML HealthTree University for Blood Cancers 5:23 2 years ago 23 704 Далее Скачать
Clinical Data for CPX-351 Versus 7+3 Therapy in AML-MRC Targeted Oncology 6:27 6 years ago 54 Далее Скачать
Challenges in treating AML VJHemOnc – Video Journal of Hematology & HemOnc 1:07 3 years ago 130 Далее Скачать
Gene-based treatments show positive outcomes in AML VJHemOnc – Video Journal of Hematology & HemOnc 4:42 6 years ago 104 Далее Скачать
Dr. Erba on FLT3 Inhibitors in Development for AML Targeted Oncology 2:54 10 years ago 165 Далее Скачать
EHA 2022 | Harry Erba | Quizartinib, FLT3 Inhibitor Boosts Overall Surivival in AML #AML HealthTree Foundation for Blood Cancers 2:27 2 years ago 103 Далее Скачать
